Discover
SXTP
60 Degrees Pharmaceuticals, Inc.
1.75
10 x 1.62
2 x 2.16
bid
ask
-
0.01
0.57%
6 @ 04:00 PM
1.73 -0.02 (1.14%)
| Ytd | -13.79% | |
| 1y | -81.54% |
1.66
day range
1.92
1.22
52 week range
10.77
| Open | 1.66 | Prev Close | 1.76 | Low | 1.66 | High | 1.92 | Mkt Cap | 4.65M |
| Vol | 173.32K | Avg Vol | 124.27K | EPS | -6.76 | P/E | N/A | Forward P/E | -0.65 |
| Beta | N/A | Short Ratio | 0.34 | Inst. Own | 1.25% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 1.55 | 200-d Avg | 3.20 | 1yr Est | 3.40 |
SXTP News
benzinga.com
60 Degrees Pharma's B-Free Babesiosis Trial Clears Initial Safety Review, Advances After DSMB Recomm
60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP, SXTPW))) ("60 Degrees Pharma" or the "Com
globenewswire.com
60 Degrees Pharmaceuticals Announces Positive Recommendation from Data Safety Monitoring Board for B
WASHINGTON, July 01, 2026 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
60 Degrees Pharma Executes Patent Licensing Agreement With Florida State University To Commence Larg
License allows the Company to commence large-scale extraction of castanospermine from the seeds of C
benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
60 Degrees Pharmaceuticals Says Co. May Submit NDA For Tafenoquine To FDA Before End Of Q1 2028
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001946563/000121390026064796/ea0293532-8k_60degrees